日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Identification of a RIPK2-Regulated Gene Signature as a Candidate Biomarker for RIPK2 Activity and Prognosis in Prostate Cancer

鉴定RIPK2调控基因特征作为前列腺癌中RIPK2活性和预后的候选生物标志物

Elgehama, Ahmed M; Yang, Qian; He, Zaoke; Ruegg, Lauryn; You, Sungyong; Yang, Wei

Oncogenic EFNA4 Amplification Promotes Lung Adenocarcinoma Lymph Node Metastasis

致癌基因EFNA4扩增促进肺腺癌淋巴结转移

Zhao, Xiangyu; Chen, Yuxing; Sun, Xiaoqin; He, Zaoke; Wu, Tao; Wu, Chenxu; Chen, Jing; Wang, Jinyu; Diao, Kaixuan; Liu, Xue-Song

Ggct (γ-glutamyl cyclotransferase) plays an important role in erythrocyte antioxidant defense and red blood cell survival

Ggct(γ-谷氨酰环化转移酶)在红细胞抗氧化防御和红细胞存活中起重要作用

Zaoke He, Xiaoqin Sun, Shixiang Wang, Dongsheng Bai, Xiangyu Zhao, Ying Han, Piliang Hao, Xue-Song Liu

Pan-cancer noncoding genomic analysis identifies functional CDC20 promoter mutation hotspots

泛癌非编码基因组分析鉴定出功能性CDC20启动子突变热点

He, Zaoke; Wu, Tao; Wang, Shixiang; Zhang, Jing; Sun, Xiaoqin; Tao, Ziyu; Zhao, Xiangyu; Li, Huimin; Wu, Kai; Liu, Xue-Song

Can tumor mutational burden determine the most effective treatment for lung cancer patients?

肿瘤突变负荷能否决定肺癌患者最有效的治疗方案?

Wang, Shixiang; He, Zaoke; Wang, Xuan; Li, Huimin; Wu, Tao; Sun, Xiaoqin; Wu, Kai; Liu, Xue-Song

Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction

抗原呈递和肿瘤免疫原性在癌症免疫治疗反应预测中的作用

Wang, Shixiang; He, Zaoke; Wang, Xuan; Li, Huimin; Liu, Xue-Song

Ras Downstream Effector GGCT Alleviates Oncogenic Stress

Ras下游效应子GGCT减轻致癌应激

Zaoke He, Shixiang Wang, Yuanyuan Shao, Jing Zhang, Xiaolin Wu, Yuxing Chen, Junhao Hu, Feng Zhang, Xue-Song Liu

APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer

APOBEC3B 和 APOBEC 突变特征作为非小细胞肺癌免疫治疗反应的潜在预测标志物

Wang, Shixiang; Jia, Mingming; He, Zaoke; Liu, Xue-Song